DEVELOPMENT AND FUNCTION OF THE HUMAN PLACENTA
==============================================

Development of the human placenta is critical for embryonic development and successful pregnancy outcome. Immediately after implantation, trophectodermal cells forming the outermost epithelial layer of the blastocyst give rise to diverse trophoblast cell types ([@B50]; [@B33]). Cell fusion generates the primitive syncytium underneath the implanted embryo, which may represent the earliest invasive trophoblast cell type migrating into the maternal endometrium (**Figure [1A](#F1){ref-type="fig"}**). After formation of the lacuna system, the ancestor of the intervillous space, cytotrophoblasts (CTBs) emanating from the trophectodermal layer generate primary villi by proliferation and invasion through the primitive syncytium (**Figure [1B](#F1){ref-type="fig"}**). Throughout pregnancy, these primary villi transform into secondary and tertiary villi characterized by invasion of extraembryonic mesenchymal cells, villous branching, and vascularization. During the first trimester of pregnancy two types of mature villi can be discriminated, which are floating and anchoring villi (**Figure [1C](#F1){ref-type="fig"}**). Floating villi connected to the intervillous space represent the transport units of human placenta. After establishment of blood flow nutrients and oxygen pass the epithelial layers of these villi ensuring appropriate fetal development and growth. Multinucleated syncytiotrophoblasts covering the surface of floating villi are continuously generated by asymmetrical cell division, differentiation and fusion of villous cytotrophoblasts (vCTBs) with the developing syncytium ([@B5]). The latter also secretes numerous hormones, such as human chorionic gonadotrophin, into the maternal circulation, which are required for maintenance and immunological adaptation of pregnancy ([@B13]). Fusion process and numbers of vCTBs decrease during pregnancy. Hence at term, syncytiotrophoblasts are in close contact with placental vessels allowing efficient nutrient uptake by the fetus.

![**Critical steps of human placental development. (A)** After implantation stems cells of the trophectoderm give rise to the primitive syncytium by cell fusion. In this region lacunae, the ancestor of the intervillous space, are formed. Some of the lacunae erode uterine vessels. **(B)** At a subsequent stage, proliferative cytotrophoblasts (CTBs) emanate from the trophectoderm, break through the primitive syncytium and contact the basal plate thereby forming primary villi. **(C)** Tertiary villi are built upon migration of extraembryonic mesodermal cells into the primary structures and vascularization. At distal sites, proliferative cell columns are formed which give rise to different invasive extravillous trophoblast subtypes. iCTBs migrate into decidual stroma approach vessels from outside and eventually form giant cells as the end stage of the invasive differentiation pathway. Endovascular trophoblasts migrate into spiral arteries and contribute to uNK cell-initiated remodeling within the decidua and the upper part of the myometrium. AE, amniotic epithelium; CCT, cell column trophoblast; DF, decidual fibroblast; EB, embryoblast; EM, extraembryonic mesoderm; eCTB, endovascular cytotrophoblast; GC, giant cell; ICM, inner cell mass, iCTB, interstitial cytotrophoblast; LUE, luminal uterine epithelium; L, lacunae, pF, placental fibroblast; PS, primitive syncytium; pV, placental vessel; SA, spiral artery; S, syncytium; TE, trophectoderm; UG, uterine gland; uNK, uterine NK cell; UV, uterine vessel; vCTB, villous cytotrophoblast.](fgene-04-00190-g001){#F1}

Villi connected to the basal plate of the human placenta give rise to proliferative cell columns from which differentiated extravillous trophoblast (EVT) cell types are generated. At early stages of pregnancy, invasive endovascular cytotrophoblasts (eCTBs) plug the maternal arterioles to prevent premature onset of blood flow into the intervillous space ([@B106]). Failures in this process were shown to be associated with pregnancy complications such as abortions likely due to the premature rise in oxygen levels which may provoke oxidative stress and damage of placental villi ([@B61]; [@B24]). Besides endovascular invasion, interstitial cytotrophoblasts (iCTBs) migrate into the maternal decidua likely cross-talking to diverse uterine cell types, including uterine natural killer cells, macrophages, and decidual stromal cells ([@B22]; [@B101]). These interactions are thought to be important for immunological acceptance of the placental/fetal allograft as well as for the timing and depth of trophoblast invasion ([@B117]). In particular, interaction of paternal human leukocyte antigen (HLA)-C expressed on iCTBs with maternal killer cell immunoglobulin-like receptors (KIR) are thought to play a pivotal role in placentation and reproductive success ([@B59]). In the absence of blood flow, trophoblast invasion might be controlled by factors secreted from uterine glands, such as epidermal growth factor (EGF) and vascular endothelial growth factor (vEGF), which are also thought to be crucial for placental and embryonic growth at this early stage of pregnancy ([@B23]). With the establishment of the maternal-placental circulation, the placenta switches from histiotrophic to haemotrophic nutrition around the 12th week of gestation, plugging of vessels is dissolved and extensive remodeling occurs. Transformation of the maternal spiral arteries into large diameter vessels likely ensures adapted nutrient supply, reduced vessel contractility and constant oxygen delivery at low blood pressure to the developing fetus ([@B24]). Vessel remodeling might be initiated by uterine NK cells and both types of differentiated EVTs are thought to play a crucial role in completing this process ([@B120]). Whereas eCTBs displace maternal endothelial cells and remodel decidual and superficial myometrial spiral arteries, iCTBs approach the vessels from outside and contribute to elastolysis and disruption of the vascular wall. This involves a series of events such as trophoblast-induced apoptosis of vascular smooth muscle cells ([@B51]). Failures in EVT invasion, remodeling and CTB gene expression were noticed in different pregnancy diseases such as preeclampsia or severe intrauterine growth restriction ([@B105], [@B106]; [@B150]). Abnormal contractility and pressure may provoke hypoxia re-oxygenation injuries of floating villi thereby inducing secretion of adverse cytokines and antiangiogenic molecules such as soluble Fms-like tyrosine kinase-1 (sFLT-1) and elevated shedding of syncytiotrophoblast microparticles ([@B24]; [@B118]; [@B128]). The latter are thought to contribute to maternal endothelial cell dysfunction as part of a global, systemic inflammatory response observed in preeclampsia.

DIFFERENTIATION AND INVASION OF HUMAN EXTRAVILLOUS TROPHOBLAST
==============================================================

Differentiation of proliferative CTBs into growth-arrested EVTs, invading decidual tissue and vessels, is thought to involve a series of well-controlled molecular steps which, however, are poorly understood. This is partly due to the fact that EVT differentiation *in vitro* can only be studied upon access to first trimester placental samples, which in general is limited due to ethical considerations. Growth of the trophoblast cell column harboring progenitor cells for the invasive differentiation pathway may involve paracrine factors released from the underlying placental mesenchyme such as IGF molecules which also promote proliferation of vCTBs *in vitro* ([@B7]; [@B40]). Since spontaneous outgrowth and migration in villous explant cultures is achieved in the absence of serum, it is likely that the intrinsic molecular program of the placental villus is also sufficient for the particular differentiation process *in vivo*. However, the precise mechanisms controlling integrity and stability of cell columns allowing for balanced rates of growth and differentiation have not yet been elucidated. Adhesive interactions between L-selectin expressed in cell columns and its carbohydrate ligands could play a role ([@B114]). Moreover, different transcription factors such as oxygen-dependent hypoxia-inducible factor 1α (HIF1α ) and Stox1, discussed elsewhere in this issue, are critical for trophoblast cell proliferation and inhibit differentiation into EVTs ([@B28]; [@B135]). In contrast, AP-2α , signal transducer and activator of transcription 3 (STAT3) or glial cells missing 1 (GCM1) promote trophoblast invasion and GCM1 was also shown to inhibit proliferation of vCTBs ([@B107]; [@B12]; [@B16]). Hence, it is assumed that a set of key regulatory transcription factors controls the switch between trophoblast proliferation and EVT differentiation ([@B79]; [@B69]). EVT formation is accompanied by the expression of distinct intergrins which are induced in a distance-dependent manner *in vivo* as well as *in vitro* ([@B34]; [@B6]). Again, the molecular basis for differentiation-dependent integrin switching remains unknown. Increasing oxygen concentrations during pregnancy and contact with the decidual matrix likely play major roles. Interestingly, accumulating evidence suggests that failures in EVT differentiation could contribute to the pathogenesis of pregnancy diseases with restricted trophoblast invasion and remodeling. Expression of inhibitor of DNA binding 2 (Id2), blocking the binding activity of differentiation-promoting basic helix-loop-helix (bHLH) proteins through heterodimerisation, was shown to be downregulated in EVTs of normal pregnancy but maintained in preeclamptic placental tissue ([@B65]). Along those lines, inhibition of HIF1α -dependent TGFβ3, acting as a negative regulator of trophoblast invasion, restored migration in explant cultures of preeclamptic villi emphasizing the particular role of oxygen in EVT differentiation ([@B26], [@B27]). Moreover, upregulation of EVT-specific genes and invasion were impaired in trophoblasts isolated from preeclamptic placentae ([@B75]). Of importance, eCTBs express a characteristic pattern of vascular adhesion molecules which, however, is abnormal in preeclamptic tissues ([@B148]).

While the hierarchy and cross-talk of critical molecular events controlling EVT differentiation await further investigations, regulation of trophoblast invasion has been investigated in a vast number of studies using primary cells, choriocarcinoma cells and established non-tumorigenic trophoblast cell lines. The different invasive trophoblast cell types produce sets of proteases, i.e., matrix metalloproteinases (MMP), urokinase plasminogen activator (uPA) and cathepsins, which are thought to degrade decidual extracellular matrix proteins and thereby facilitate cell invasiveness. The respective inhibitors, tissue inhibitors of metalloproteinases (TIMPs) and plasminogen activator inhibitors (PAIs) are produced by EVTs as well as decidual cells to limit the extent of trophoblast invasion. Numerous soluble factors expressed at the fetal-maternal interface including chemokines, cytokines and angiogenic factors were shown to promote trophoblast motility in an autocrine or paracrine manner ([@B20]; [@B72]; [@B68]). As a common theme, the secreted proteins were shown to stimulate MMP expression and secretion, in particular the gelatinases MMP-2 and MMP-9. Inhibitory proteins such as TNF, Nodal or TGFβ could restrain trophoblast motility by increasing expression of TIMPs and PAIs ([@B73]; [@B49]; [@B96]). Although a complex interplay of growth factors likely controls trophoblast cell migration and invasion, it remains unclear whether all of the currently identified effects truly play a role *in vivo*. Tumorigenic and non-tumorigenic cell types as well as hybridomas used in functional studies may not accurately mimic trophoblast cell behavior. Indeed, overall gene expression profiles of primary CTBs and EVT cultures differ considerably from the different established trophoblast cell lines ([@B18]). Moreover, compared to primary cells, a diverging HLA profile was identified in the immortalized trophoblast cell lines. Villous CTBs lack surface expression of classical HLA molecules, but EVTs produce HLA-C, -E, and -G upon differentiation. JEG-3 choriocarcinoma cells show a similar HLA profile as EVTs, whereas several immortalized cell lines produce HLA-A and -B, suggesting abnormal activation of these genes during the immortalization procedure or a non-trophoblastic origin of these cells ([@B8]).

Furthermore, published literature suggests key signaling pathways that are involved in trophoblast motility. Abundant growth factors such as hCG, EGF, HGF, or IGF2 activate MAPK kinase (MEK)/extracellular regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling, whereas prostaglandins were shown to act through the Rho-Rock pathway ([@B112]; [@B68]). Besides expression of TIMPs and PAIs, downregulation of signaling kinase activity could represent a mechanism to limit the extent of trophoblast invasion. For example endostatin, which could be released from decidual collagen XVIII by EVT-mediated proteolytic cleavage, was shown to impair growth factor-induced AKT/mTOR phosphorylation and cell migration ([@B109], [@B111], [@B110]).

To identify novel genes and pathways controlling trophoblast motility and differentiation we and others recently performed comparative gene expression studies of CTBs and EVTs isolated from first trimester placental tissues. Chip-based profiling of EGFR-positive CTBs, isolated by flow cytometry, and EVTs, generated by seeding of the CTBs on fibronectin for 12 h, resulted in the identification of 3433 mRNAs which are at least two-fold differentially expressed between the two cell populations ([@B9]). Using immunopurified CTBs and EVTs isolated from outgrowths of villous explant cultures and gene chips with a lower number of probe sets compared to the aforementioned study, we detected 991 differentially expressed transcripts in our analyses ([@B17]). One of these mRNAs which was found to be induced upon EVT differentiation encoded TCF-4, one of the key transcription factors in Wnt signaling ([@B121]). Hence, this result prompted us to investigate the expression pattern of Wnt signaling components and the general role of the canonical signaling pathway in human trophoblast migration and invasion.

Wnt SIGNALING PATHWAYS
======================

Besides Hippo, Hedgehog, Notch and TGFβ signaling, Wnt signaling represents one of the few conserved pathways critically involved in developmental processes. From *Drosophila* to human, the particular signal transduction cascade controls early axis formation, limb patterning and organogenesis ([@B78]; [@B31]). In adults, Wnt controls homeostasis of regenerating tissues such by regulating stem cell maintenance, cell fate decisions and differentiation ([@B31]; [@B57]). Abnormal Wnt signaling has been described in a variety of human diseases including different cancers, diabetes or neurodegenerative disorders ([@B108]; [@B1]). Wnts comprise a family of palmitoylated, cysteine-rich glycoproteins, which due to their low solubility are secreted in a lipoprotein-bound form or through exosomes ([@B57]). The first described member of this family of secreted ligands was the Wnt1 proto-oncogene, which is homologous to the *Drosophila* gene Wingless. Originally, the gene has been named int-1 since it has been identified as an integration site for the murine mammary tumor virus which can provoke breast cancer ([@B100]). In humans, 19 different Wnt ligands and 10 seven-transmembrane domain frizzled (Fzd) receptors have been identified ([@B139]). The latter interact with low density lipoprotein receptor related proteins (LRP-5 or -6) forming a functional, heterodimeric receptor for canonical Wnt signaling. It is likely that the complex interplay of different Wnts with Fzds provokes specific Wnt responses depending on the receptor context and the particular cell type. Stabilization and nuclear recruitment of β -catenin is a hallmark of the canonical pathway. However, Wnt ligands also trigger non-canonical, β -catenin-independent signaling including the Wnt/Ca^2+^ and the Wnt/planar cell polarity (PCP) pathway ([@B46]; [@B56]; [@B133]).

CANONICAL Wnt SIGNALING
-----------------------

Canonical Wnt signaling involves a series of steps resulting in the stabilization and nuclear translocation of β -catenin ([@B46]). In unstimulated cells, β -catenin is predominantly found at adherens junctions where it binds to E-cadherin and α -catenin and thereby maintains epithelial structure and polarity. Cytosolic levels of β -catenin are low since it is degraded in a destruction complex consisting of adenomatous polyposis coli (APC), Axin, casein kinase Iα (CKIα ) and glycogen synthase kinase 3β (GSK-3β ). The latter phosphorylates β -catenin at its N-terminus and thereby induces binding of β -transducin repeat-containing protein (β -TrCP) and its associated E3 ubiquitin ligase. This results in ubiquitination and proteasomal degradation of β -catenin ([@B127]). In contrast, Wnt stimulation promotes Fzd-LRP heterodimerisation and cytosolic stabilization of β -catenin by disruption of the APC/Axin/GSK-3β /CK1α destruction complex. Upon binding of Wnt to the cysteine-rich domain of Fzd, the multifunctional protein Disheveled (Dvl) is recruited to the cytosolic portion of the heterodimeric receptor and thereby provokes binding of Axin and GSK-3β as well as GSK-3β -mediated phosphorylation of LRP-5/6 ([@B82]; [@B19]). This event could either inhibit the catalytic activity of GSK-3β toward β -catenin promoting sequestration or induce internalization and lysosomal degradation of components of the destruction complex ([@B87]). As a consequence cytoplasmic concentrations of β -catenin increase and active de-phosphorylated β -catenin translocates to the nucleus where it binds to transcription factors of the lymphoid enhancer factor-1 (LEF-1)/TCF family ([@B31]; [@B46]). LEF/TCF proteins are high mobility group proteins lacking transcriptional activity and hence require co-activators or co-repressors for their function. Binding of β -catenin to LEF/TCF converts these proteins into transcriptional activators by displacing histone deacetylases (HDACs) and inhibitors of the Groucho protein family followed by recruitment of the Legless family docking protein Bcl9, CBP/p300 and histone acetylases ([@B46]; [@B11]). Activation of LEF-1/TCF then provokes transcription of numerous genes controlling developmental processes, cell cycle, differentiation and cell invasion such as cyclin D1, c-myc, c-jun, MMPs, urokinase plasminogen activator receptor (uPAR), Notch signaling factors and many others depicted at the Wnt homepage^[1](#fn01){ref-type="fn"}^. Moreover, Wnt signaling components such as Axin, TCFs or Fzds are often controlled by a feedback loop upon Wnt activation. Accumulating evidence, however, suggests that our view of canonical Wnt signaling is still too simplistic. Proteins of the destruction complex can enter the nucleus and influence trafficking of Wnt signaling components as well as gene transcription. Numerous soluble negative regulators of Wnt signaling such as different Dickkopf (Dkk) or secreted frizzled-related proteins (sFRPs) binding to Wnts and LRP, respectively, have been identified ([@B46]). TCFs interact with several other regulatory transcription factors, for example Smads, c-jun or Cdx proteins, likely determining specificity of binding to Wnt response elements ([@B11]). Moreover, TCF/β -catenin transcriptional complexes can also repress transcription and β -catenin can be recruited to other transcription factors than LEF/TCF, e.g., steroid hormone receptors, in a Wnt-dependent manner ([@B15]).

Several alterations in Wnt signaling components have been detected in cancer cells provoking nuclear accumulation of β -catenin and aberrant Wnt signaling ([@B25]). While mutations in Wnt ligands are rare, mutations in the APC tumor suppressor gene have been identified in the majority of sporadic colorectal cancers. Moreover, activating mutations in β -catenin inhibiting its GSK-3β -dependent degradation were detected in colon, prostate and other malign tumors. In addition, there is also compelling evidence that epigenetic changes of the Wnt pathway contribute to tumorigenesis since downregulation of sFRP gene transcription through promoter methylation has been observed in different epithelial cancers ([@B57]).

NON-CANONICAL Wnt SIGNALING
---------------------------

The fact that different Wnts can exert effects on cells independently of β -catenin adds further complexity to the particular signaling pathway. Ligands such as Wnt5a or Wnt11 can activate the Wnt/PCP and the Wnt/Ca^2+^ pathway by binding to Fzds and activating Dvl independently of LRP-5 or -6 ([@B71]). Induction of Wnt/PCP signaling, originally identified in different developmental processes of *Drosophila*, involves the G-proteins Rac and RhoA and the downstream effectors c-jun NH~2~-terminal kinase (JNK) and Rho-associated kinase (ROCK), respectively. Wnt/PCP signaling is critically involved in the formation of embryonic tissues and organs and aberrant activation of the pathway was shown to promote metastasis of different cancer types ([@B137]).

On the other hand, Wnt/Ca^2+^ signaling inhibits cGMP-dependent protein kinase (PKG), which blocks Ca^2+^ release in unstimulated cells and activates phospholipase C (PLC) and elevation of inositol 1,4,5-trisphosphate (IP~3~) thereby releasing Ca^2+^ from the endoplasmic reticulum ([@B70]). Increased cytosolic Ca^2+^ levels finally stimulate activity of protein kinase C (PKC), calcium/calmodulin-dependent kinase II (CamKII) and calcineurin which provoke nuclear recruitment of nuclear factor κ B (NFκ B) and of nuclear factor of activated T cells (NF-AT) ([@B123]; [@B81]; [@B35]). In addition, Ca^2+^ accumulation upon Wnt5a stimulation can induce TGF-β -activated kinase (TAK1) and Nemo-like kinase (NEMO), which block TCF through phosphorylation and antagonize canonical Wnt signaling ([@B64]; [@B63]). Hence, in some cancers Wnt5a acts as a tumor suppressor. However, the effects of Wnt5a strongly depend on the receptor context. Binding to Fzd2, 3, 5, 6 induces Ca^2+^ signaling, but the ligand can also activate the canonical pathway upon interaction with Fzd4 and LRP ([@B88]; [@B98]). Moreover, various studies suggest that different Wnts can interact with the receptor tyrosine kinases Ryk and Ror2 and promote developmental processes independently of Fzd or activate classical signaling pathways such as ERK or PI3K/AKT/mTOR ([@B144]; [@B67]; [@B41]; [@B90]). In conclusion, Wnts binding to canonical and diverse non-canonical receptors form a highly complex signaling network with a considerable overlap between the different pathways.

Wnt SIGNALING IN PLACENTA AND TROPHOBLAST
=========================================

As outlined above and discussed elsewhere, early placental development is associated with rapid generation of several trophoblast subtypes forming distinct functional villi in mice and men ([@B44]; [@B116]). Likewise, the maternal uterus adapts to pregnancy by extensive tissue remodeling involving differentiation of stromal cells, angiogenesis and immunological alterations. These critical processes are initiated during the secretory phase of the menstrual cycle and upon implantation and early stages of placental development. Given the fact that Wnt signaling is important for organ development and tissue homeostasis, it may not be surprising that the pathway also has major roles in uterus formation, growth and differentiation. Gene targeting in mice revealed that β -catenin and different Wnts, such as Wnt4, Wnt5a, or Wnt7a, are critical for uterine development ([@B89]; [@B132]; [@B86]; [@B10]). Wnt signaling components also play a role in stroma cell proliferation and differentiation for example Wnt4, Wnt6 ([@B74]; [@B136]) or Dkk1, a progesterone-regulated gene which is induced in the endometrium upon decidualization ([@B131]; [@B38]).

This review focuses on function of Wnt signaling in trophoblast and placental development and differentiation, whereas a number of different papers summarize the role of canonical and non-canonical Wnt signaling in female reproductive tract development and differentiation, uterine function and decidualization ([@B30]; [@B126]; [@B134]; [@B138]).

Wnt SIGNALING IN MURINE PLACENTAL DEVELOPMENT
---------------------------------------------

Expression of several Wnt ligands, Fzds and Dvl proteins has been noticed in the developing murine blastocyst during the pre-implantation period ([@B91]; [@B53]). However, the canonical pathway does not seem to play a role in blastocyst formation. Embryos bearing homozygous deletion of β -catenin develop to the blastocyst stage but are affected upon gastrulation ([@B48]). However, maternal β -catenin may have compensated the lack of embryonic β -catenin. Therefore, mothers harboring a conditional deletion of the gene in oocytes were additionally used in β -catenin knock-out studies ([@B37]). Again, development into blastocysts was observed suggesting that β -catenin is not required for early pre-implantation development. Also, treatment with Dkk1 did not impair blastocyst formation ([@B143]). Non-canonical signaling such as the Wnt/Ca^2+^ pathway could be involved ([@B30]). On the other hand, there is evidence that the canonical Wnt pathway could regulate blastocyst development in other species for example in ruminants ([@B36]).

Whereas the canonical Wnt pathway is dispensable for murine blastocyst development, it is critical for blastocyst activation, adhesion and implantation. Inhibition of the pathway through Dkk1 or small molecular inhibitors decreased implantation, which was also shown to be associated with induction of canonical β -catenin and downregulation of non-canonical Wnt-RhoA signaling ([@B143]). Likewise, treatment with sFRP2 was shown to decrease implantation rates ([@B92]). Induction of the canonical pathway in the uterine epithelium and myometrial smooth muscle cells at the site of implantation through trophectoderm-derived Wnt ligands seems to be important ([@B92]).

Wnt signaling could also play a key role during early trophoblast development in mice. Treatment of embryonic stem cells with Wnt3a induced formation of trophectodermal stem cells with the capacity to differentiate into spongiotrophoblasts and giant cells which was mediated through LEF-1-dependent induction of Cdx2, a key regulator of early trophoblast lineage determination ([@B29]; [@B55]).

Furthermore, gene targeting in mice provided evidence that Wnt signaling components control sequential steps of placental development. In particular, chorioallantoic fusion, branching morphogenesis, labyrinth development and placental angiogenesis were affected in these mutants ([@B32]). For example, gene knock-outs of Wnt7b, R-spondin3, a soluble activator of canonical Wnt signaling, or of both TCF-1 and LEF-1 show defects in chorioallantoic fusion thereby altering normal labyrinth development and function at later stages of embryogenesis ([@B43]; [@B102]; [@B4]). Similar to the above mentioned mutants, homozygous deletion of Wnt2 and Fzd5 affected branching and labyrinth formation, however, without alterations in chorioallantoic fusion ([@B93]; [@B62]). Moreover, placentae lacking Bcl-9, one of the co-activators of LEF-1/TCF, showed defective branchpoint initiation and a decrease in syncytiotrophoblast formation ([@B84]). GCM1, the key transcription factor in branching morphogenesis and trophoblast cell fusion ([@B3]), is probably the most critical Wnt target in mouse placental development since diminished expression of GCM1 was noticed in R-spondin3 and Bcl-9-mutant placentae ([@B4]; [@B84]). Indeed, a recent study indicated that a positive feedback loop of Fzd5 and GCM1 controls different steps of placental morphogenesis promoting branchpoint initiation, chorionic trophoblast-specific vEGF expression and trophoblast syncytialisation ([@B80]). Placental phenotypes of mice with homozygous deletions of Wnt signaling genes are summarized in **Table [1](#T1){ref-type="table"}**. Early stages of murine trophoblast invasion, however, might be negatively affected by canonical Wnt signaling since recombinant Dkk1 was shown to increase motility in co-cultivations of ectoplacental cones with decidual cells ([@B103]).

###### 

Placental phenotypes of mice with homozygous deletion of Wnt signaling components.

  Gene knock-out   Phenotype                                                              Reference
  ---------------- ---------------------------------------------------------------------- ----------------
  Wnt2             Defects in labyrinthine zone                                           [@B93]
                   Decreased number of fetal capillaries                                  
                   Oedema formation                                                       
                   Fibrinoid deposition                                                   
  Wnt7b            Defect in alpha4-mediated chorioallantoic fusion                       [@B102]
                   Disorganization of chorionic plate                                     
  R-spondin3       Defects in chorioallantoic fusion, branching and labyrinth formation   [@B4]
                   Reduced expression of Gcm1                                             
  Fzd5             Defects in yolk sac angiogenesis and placental vasculogenesis          [@B62]; [@B80]
                   Defective chorioallantoic branching                                    
                   Decreased GCM1 expression                                              
  Bcl9             Defective branching initiation                                         [@B84]
                   Failures in trophoblast syncytialisation                               
  LEF-1/TCF-1      Defects in chorioallantoic fusion                                      [@B43]

EXPRESSION PATTERNS OF Wnt LIGANDS AND FRIZZLED RECEPTORS IN HUMAN TROPHOBLASTS
-------------------------------------------------------------------------------

Human trophoblast development is mostly studied in choriocarcinoma model systems and immortalized trophoblast cell lines, since primary placental material can only be obtained from very restricted time points during pregnancy. Trophoblast cell fusion can be investigated in isolated term CTBs involving numerous effectors ([@B94]). Invasive properties of cells are lost at the end of pregnancy and therefore trophoblast motility and differentiation of progenitors into EVTs has to be analyzed in first trimester placentae using villous explant cultures and/or isolated CTBs ([@B112]). Investigations in these primary cultures as well as in cell lines provided evidence for an autocrine role of Wnt signaling in human trophoblast proliferation and invasion ([@B126]). As a first step, our laboratory analyzed the expression patterns of all Wnt ligands and Fzd receptors in different trophoblast cell lines, isolated CTBs and total placental extracts of first and third trimester, as well as in villi and EVTs obtained from first trimester villous explant cultures using optimized, semi-quantitative RT-PCR ([@B125]). 14 out of 19 Wnt ligands, and 8 out of 10 Fzd receptors were found to be expressed in total first trimester placenta. Most of these mRNAs were detectable in the villous trophoblast epithelium. In particular, abundantly (Wnt1, Wnt2b, Wnt4, Wnt7b, Wnt10a, Wnt10b, Wnt11), moderately (Wnt5a, Wnt9b) and lowly (Wnt2, Wnt3, Wnt5b, Wnt6, Wnt7a) -expressed Wnt ligands were present in first trimester CTBs as depicted (**Figure [2](#F2){ref-type="fig"}**). Hence, expression of canonical (for example Wnt1, Wnt2b, Wnt7b, Wnt10a, Wnt10b) as well as non-canonical Wnts (Wnt4, Wnt5a, Wnt11) suggests that different Wnt pathways may operate during human trophoblast development. Wnt1, Wnt7b, Wnt10a, and Wnt10b were downregulated from first trimester to term suggesting roles in trophoblasts of early pregnancy ([@B125]). Whereas Fzd2 and Fzd4 are only produced in villous mesenchymal cells, Fzd1, Fzd3, Fzd5, Fzd6, Fzd7, and Fzd10 are expressed in CTBs. The latter was absent from villous fibroblasts suggesting a specific role in CTBs. Although none of the individual Wnts and Fzds have been studied in the context of human trophoblast invasion and differentiation so far, expression patterns and comparison to the situation in mouse placenta and other Wnt-dependent systems in reproduction allows to speculate about their potential roles.

![**Schematic illustration of transcript levels encoding Wnt ligands and Fzd receptors in isolated human first trimester CTBs and EVTs measured by semi-quantitative RT-PCR as published elsewhere ([@B125]).** Low, medium and high levels of expression are indicated by one, two and three black squares, respectively.](fgene-04-00190-g002){#F2}

Wnt4 is produced by CTBs as well as EVTs and could contribute to decidualization through the canonical pathway ([@B74]). Wnt5a, secreted from trophoblast cell lines and primary cultures, may act through non-canonical pathways since it was unable to induce TCF/β -catenin-dependent transcription but antagonized the canonical pathway in trophoblasts ([@B125]). Progesterone treatment of ovariectomized mice was shown to stimulate Wnt11 expression, another non-canonical Wnt ligand, whereas Wnt4 and Wnt7b are induced by estrogen which likely has implications for implantation ([@B54]) and decidualization as mentioned above. Interestingly, Wnt4, Wnt11 and Wnt7b are among the most abundantly produced Wnts in CTBs and Wnt7b expression decreased during EVT formation (**Figure [2](#F2){ref-type="fig"}**). Considering that Wnt7b is required for mouse placental development ([@B102]), the human homologue may also play a role in placenta formation and/or control critical functions during the first trimester of pregnancy such as trophoblast proliferation. Similarly, Wnt10a, Wnt10b, Fzd5, and Fzd10 were strongly expressed in CTBs but largely absent from EVTs or placental fibroblasts suggesting that these Wnt and Fzd members are also predominantly associated with early trophoblast cell growth. The principal Fzd receptor in EVTs is Fzd6, which operates through canonical as well as non-canonical pathways ([@B45]; [@B142]). Differential expression of Fzds between CTBs and EVTs is also detectable in our previously established gene expression profiles ([@B17]) as shown in **Figure [3](#F3){ref-type="fig"}**. Whereas the role of Wnt10a, Wnt10b or FZD10 in murine placental development is unknown, Fzd5 is critical for branching morphogenesis as mentioned before ([@B80]). Hence, Fzd5 could also play a crucial role in human placental development. Furthermore, another semi-quantitative RT-PCR study suggested that several of the above mentioned Wnt ligands are regulated in a gestation-dependent manner in first trimester placenta ([@B47]) suggesting that specific combinations of Wnts could eventually control sequential steps of human trophoblast function and/or development. Moreover, the endometrial Wnt ligands Wnt2, Wnt4, Wnt5a, Wnt7a, Wnt8b, and Wnt3, the latter being regulated during the menstrual cycle, could affect trophoblast function in a paracrine manner ([@B130]).

![**Color-coded mRNA expression (GDS3523) in non-invasive CTBs (5 pools) and invasive EVTs (6 pools) analyzed by GEO DataSet Cluster Analysis online tool (<http://www.ncbi.nlm.nih.gov/geo/>).** Markers of EVT differentiation, Fzd receptors, putative TCF-4/β -catenin target genes as well as biomarkers of EMT are depicted.](fgene-04-00190-g003){#F3}

Wnt SIGNALING IN HUMAN TROPHOBLAST FUNCTION AND DIFFERENTIATION
---------------------------------------------------------------

Studies in mice suggested that Wnt signaling is critical for activation and implantation of blastocysts ([@B92]). *In vitro* investigations with trophoblast cell lines and cultures also revealed a role of the particular signaling pathway in human trophoblast adhesion, invasion and differentiation.

Treatment of decidualized stromal cells with supernatants of trophoblasts provoked changes in the expression of some Wnt signaling components suggesting that soluble trophoblast-derived factors could influence endometrial function and differentiation through regulation of the Wnt pathway ([@B58]). Different Wnts secreted from EVTs could be the prime factors controlling expression of decidual Wnt signaling components since many of these genes are direct targets of TCF/β -catenin as summarized at the Wnt homepage^1^. Along those lines, attachment of spheroids prepared from JAR choriocarcinoma cells to endometrial Ishikawa cells was inhibited in the presence of Dkk1 ([@B77]). Similarly, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a negative effector of implantation, decreased attachment of JEG-3 or BeWo cell spheroids to different endometrial epithelial cell lines by suppressing β -catenin, which could be reverted upon treatment with a recombinant Wnt ligand ([@B129]).

Moreover, expression analyses of TCFs in human first trimester placenta suggested that the canonical Wnt pathway is associated with the invasive differentiation process of trophoblasts ([@B113]). Immunofluorescence of tissues revealed induction of TCF-4 protein in the nucleus of non-proliferating, p57/KIP2-positive EVTs as well as nuclear recruitment of β -catenin in a considerable number of these cells. Analyses of our expression profiles performed with total mRNA isolated from five and six different CTB and EVT cell preparations, respectively ([@B17]), suggested induction of TCF-4 at the mRNA level (**Figure [3](#F3){ref-type="fig"}**). Moreover, stimulation with a Wnt ligand increased invasion of primary CTBs and trophoblastic SGHPL-5 cells in transwell assays and promoted migration in villous explant cultures seeded on collagen I, which was inhibited upon treatment with recombinant Dkk1 ([@B113]; [@B124]). In addition, basal migration and invasion of the different trophoblast models were reduced in the presence of Dkk1 suggesting that the aforementioned canonical Wnts expressed in EVTs exert autocrine effects. Wnt stimulation was also shown to activate non-canonical AKT signaling and AKT-dependent motility of trophoblasts ([@B124]). Canonical LRP-5/6-FZD receptors were not involved since Wnt-dependent phosphorylation of AKT could not be inhibited upon supplementation of Dkk1. Also, cross-talk between the canonical Wnt pathway and AKT through AKT-induced phosphorylation and inactivation of GSK-3β as mentioned for other cells ([@B97]) has not been observed in trophoblasts since chemical AKT inhibitors did neither change nuclear accumulation of β -catenin nor the activity of a canonical Wnt reporter ([@B124]). One of the putative targets increasing invasiveness in a Wnt-dependent manner could be MMP-2, which is elevated in trophoblast supernatants upon Wnt stimulation and also has been described as a direct target of TCF/β -catenin ([@B141]; [@B124]). Although MMP-2 mRNA expression is associated with EVT differentiation (**Figure [3](#F3){ref-type="fig"}**), transcript levels did not change upon Wnt stimulation suggesting that the pathway induces MMP-2 secretion or affects its stability ([@B124]).

Although canonical Wnt signaling is strongly elevated upon EVT formation, CTBs also respond to Wnt signals. Wnt-dependent activation of TCF/β -catenin provoked increased proliferation and expression of the cell cycle regulator cyclin D1 as well as induction of Wnt signaling components ([@B113]). Although TCF-4 is absent from proliferative CTBs, the canonical pathway might be activated through TCF-3 which is present in both CTBs and EVTs (**Figure [3](#F3){ref-type="fig"}**).

Furthermore, epigenetic analyses provided evidence for a general activation of Wnt signaling in placental tissues and isolated trophoblasts. Genes encoding negative regulators of the pathway, i.e., APC, sFRP2 and engrailed-1 were shown to be hypermethylated in trophoblasts, whereas these changes were not observed in placental fibroblast or leukocytes ([@B99]; [@B140]). This suggests that specific activation of the pathway in trophoblasts could play a role in placentation. In addition, other effectors than Wnt ligands likely contribute to stabilization of β -catenin and TCF/β -catenin-dependent trophoblast proliferation and invasion. Activation of protease activated receptor-1 (PAR1) provoked an increase in these processes whereas siRNA-mediated gene silencing of PAR1 or addition of soluble inhibitors downregulated TCF/β -catenin-induced proliferation and motility ([@B47]). Expression of StarD7, a member of the StAR1 lipid transfer proteins promoting proliferation and invasion of choriocarcinoma cells, was shown to be directly controlled by TCF/β -catenin ([@B119]; [@B39]).

In summary, the present literature implicates canonical Wnt signaling in human trophoblast proliferation and invasion. However, the question of whether TCF molecules are indeed regulators of EVT formation, in other words control the switch from proliferation to cell cycle arrest and differentiation is still unknown and currently under investigation in our laboratory. So far, canonical Wnt signaling has been identified as a regulator of trophoblast cell fusion. GCM1, the most critical factor in syncytialisation controlling expression of the fusogenic proteins syncytin-1 and -2, harbors TCF binding sites in one of its introns and silencing of TCF-4 or β -catenin impaired cAMP-induced cell fusion of BeWo choriocarcinoma cells ([@B84]). Moreover, Wnt targets such as Axin, BMP and activin membrane-bound inhibitor (BAMBI), and LEF-1 increased upon elevation of cAMP. However, it has to be mentioned that LEF-1 is only expressed in stromal cells of human placentae and TCF-3 and -4 are absent from villous CTBs after the 6th week of gestation ([@B113]). Since trophoblast fusion occurs until the end of pregnancy, Wnt-dependent GCM1 expression and syncytialization may only operate during very early stages of human gestation. Similar to mice, Wnt signaling might also play a role in early human trophoblast lineage determination since the pathway was found to be activated upon BMP4-mediated differentiation of embryonic stem cells into trophoblasts ([@B83]).

Wnt TARGET GENES AND THE ROLE OF Wnt-DEPENDENT TRANSCRIPTION FACTORS IN EPITHELIAL TO MESENCHYMAL TRANSITION
------------------------------------------------------------------------------------------------------------

Numerous studies indicated that cancer cell invasion shares several features with trophoblast invasion although the latter is precisely controlled in time and space. Besides expression of proteases, EVTs produce critical integrins such as the fibronectin receptor integrin α5β1 and the collagen/laminin receptor integrin α1β1 promoting trophoblast adhesion and migration ([@B34]; [@B6]). Conversely, EGF receptor 1 (EGFR1), indicative for the proliferative capacity of trophoblasts as well as integrin α6 (ITGA6), a marker of the polarized epithelium, were downregulated during EVT differentiation ([@B66]). Changes in the mRNA expression pattern of genes involved in EVT invasion and differentiation can also be monitored in our published chip data ([@B17]) which are accessible via GEO profiles^[2](#fn02){ref-type="fn"}^. ITGA6 and EGFR are highly expressed in the five different CTB cell pools but weakly present in the six EVT preparations confirming the published literature (**Figure [3](#F3){ref-type="fig"}**). In contrast, HLA-G1, and the pro-migratory genes integrin α1 (ITGA1), integrin α5 (ITGA5) and fibronectin 1 (FN1) were upregulated in EVTs. Interestingly, various mRNAs such as BAMBI, a marker of metastasis in colon cancer ([@B42]), insulin-like growth factor 2 (IGF2), inducible nitric oxide synthase (iNOS), fibronectin 1 (FN1), MMP-2, Notch2, uPAR, and Snai1 (also known as Snail1), which are all direct targets of TCF/β -catenin^1^, were found to be increased in the EVT pools concomitant with the upregulation of TCF-4 (**Figure [3](#F3){ref-type="fig"}**). Indeed, these genes have already been implicated in the control of trophoblast motility ([@B20]; [@B72]; [@B52]; [@B60]). Therefore, we speculate that nuclear recruitment of β -catenin and increased expression of TCF-4 in EVTs drives a set of genes promoting trophoblast invasion and migration.

Another molecular process critically involved in cancer cell invasion and metastasis is epithelial to mesenchymal transition (EMT), in which epithelial cells lose their polarity and gain fibroblast-like properties promoting invasion and migration ([@B147]). Interestingly, EMT in cancer cells also provokes growth arrest and cells have to revert back to an epithelial phenotype (MET) allowing for cell growth and distant metastasis formation ([@B21]). Analyses of gene expression profiles suggest that EMT also occurs in invasive trophoblasts (**Figure [3](#F3){ref-type="fig"}**) which have stopped proliferation allowing for differentiation to take place. Although invasive trophoblasts do not induce mesenchymal vimentin, at least *in vitro*, and maintain expression of the epithelial marker cytokeratin 7, they upregulate typical EMT-associated mRNAs such as heat shock protein 47 (HSP47), Snail, ITGA5, ITGAB1, fibroblast-specific protein 1 (FSP1), MMP-2, and secreted protein acidic and rich in cysteine (SPARC) and downregulate genes associated with cell-cell adhesion and epithelial polarity such as the tight junction proteins occludin (OCLN) and ZO1. Also, transient loss of adherens junction proteins, i.e., membrane-bound β -catenin and E-cadherin, has been detected in the proximal invasion zone of anchoring villi using immunofluorescence in first trimester placental tissues ([@B149]). Elevated Wnt signaling, expression of LEF/TCF and nuclear recruitment of β -catenin is also a typical feature of EMT ([@B95]). Hence, similar to cancer cells, induction of TCF-4 upon invasive trophoblast differentiation could orchestrate an EMT-like program to promote cell motility. In this process, TCF-4 could act as master regulator since it may not only directly control expression of pro-migratory EMT genes but also activate other critical key regulatory transcription factors inducing EMT such as Snail, Slug or ZEB1 ([@B85]; [@B122]).

Wnt signaling in gestational diseases
-------------------------------------

Changes in gene expression as well as in epigenetic modifications of Wnt signaling components were shown to be associated with different gestational diseases. Compared to normal tissues, higher numbers of β -catenin-positive EVT nuclei were detected in placentae of complete hydatidiform mole (CHM) suggesting that aberrant Wnt signaling could contribute to abnormal invasion in this pregnancy disorder ([@B113]). Genes encoding APC and sFRP2 were shown to be hypermethylated in choriocarcinoma cells, indicating that inactivation of negative regulators of Wnt signaling likely contributes to the formation and/or progression of trophoblastic cancer cells ([@B99]; [@B140]). Similarly, Dkk1 was found to be absent from choriocarcinoma cells and re-expression of the gene induced growth arrest and apoptosis suggesting that the loss of Dkk1 is critical for tumor cell proliferation ([@B104]). In contrast, Dkk1 and sFRP4 were increased whereas Wnt2 and β -catenin were decreased in tissues of preeclamptic patients ([@B145], [@B146]). Therefore, downregulation of the pathway could contribute to failed placentation and shallow trophoblast invasion observed in these pregnancies. Along those lines, elevated levels of Dkk1 were detected in women with recurrent abortions ([@B14]). Interestingly, cytomegalovirus (CMV) infection, a putative cause of spontaneous abortion and preterm delivery, was shown to decrease trophoblast proliferation and invasion involving inhibition of Wnt signaling. Infection of trophoblastic SGHPL-4 cells with the virus altered the localization of β -catenin and induced its degradation as well as downregulation of a canonical Wnt reporter ([@B2]). Some of these effects might be exerted via peroxisome proliferator-activated receptor γ (PPAR- γ ) a negative regulator of trophoblast invasion, which is activated upon CMV infection and was shown to provoke proteasomal degradation of β -catenin in other cells ([@B76]; [@B115]).

CONCLUSIONS
===========

In conclusion, the present literature suggests that Wnt signaling is critical for physiological processes of human trophoblasts. The pathway could play a role in blastocyst adhesion, implantation and early trophoblast lineage decisions. Moreover, Wnt signaling could regulate trophoblast cell fusion as well as development of the anchoring villus controlling proliferation, invasion and differentiation. In first trimester placenta numerous canonical and non-canonical Wnt ligands are expressed in CTBs and likely regulate proliferation or other functions of these cells through the most abundant receptors, i.e., Fzd5 and Fzd10 (**Figure [4](#F4){ref-type="fig"}**). Differentiation of CTBs into growth-arrested invasive EVTs is associated with increased expression of TCF-4, nuclear recruitment of β -catenin and elevated canonical Wnt activity controlling trophoblast motility potentially through Fzd6. Furthermore, TCF-4/β -catenin could activate a set of genes promoting invasion as well as the EMT-like features of migratory trophoblasts. Hence, Wnt signaling likely contributes to the strong, intrinsic differentiation program of EVTs and their inherently invasive properties. Hyperactivation of autocrine Wnt signaling could play a role in trophoblast disorders with elevated proliferation and invasion such as CHM and choriocarcinomas whereas downregulation of the pathway could be a cause of impaired placentation and trophoblast invasion observed in preeclampsia. Epigenetic changes such as methylation of negative regulators of Wnt signaling could contribute to the induction of Wnt signaling likely promoting normal placentation as well as trophoblast tumor progression. Besides autocrine control decidual Wnt ligands could modulate trophoblast function via canonical and/or non-canonical pathways. The fact that Dkk1 is expressed in the decidua and increased upon progesterone treatment could suggest a mechanism to restrain the extent of trophoblast invasion. Further studies are needed to delineate specific Wnt-Fzd interactions in human trophoblasts and to define the role of non-canonical Wnt signaling in normal and aberrant trophoblast proliferation, invasion and differentiation.

![**Model system for the role of Wnt signaling in function and differentiation of the human anchoring villus.** Wnt ligands and Fzd receptors expressed in vCTBs/CCTs and EVTs are shown. During EVT formation, Wnt7b, Wnt9b, Wnt10a, Wnt10b, Fzd5, and Fzd10 are down-regulated suggesting a role in trophoblast proliferation. However, interstitial cytotrophoblasts (iCTBs) upregulate TCF-4 and nuclear β -catenin to promote trophoblast motility and possibly EVT differentiation.](fgene-04-00190-g004){#F4}
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